Concepedia

Debananda Das

DD

Statistics

Publications

39

Citations

2.2K

H-Index

26

Active since

1999

Affiliations

National Institutes of Health(Current)

Kumamoto University

National Cancer Institute

Purdue University West Lafayette

National Center for Global Health and Medicine

Debananda Das is an author at National Institutes of Health specializing in medicinal chemistry, pharmacology, and antiretroviral therapy.

ORCID

Publications per year

1999–2023

39

Publications

39

A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication

Shin-ichiro Hattori, Nobuyo Higashi‐Kuwata, Hironori Hayashi et al. · Nature Communications · 2021 · 192 citations · Full text

, , +17

Optimization of quantum mechanical molecular mechanical partitioning schemes: Gaussian delocalization of molecular mechanical charges and the double link atom method

Debananda Das, Kirsten P. Eurenius, Eric M. Billings et al. · The Journal of Chemical Physics · 2002 · 190 citations

, , +16

Structural and Molecular Interactions of CCR5 Inhibitors with CCR5

Kenji Maeda, Debananda Das, Hiromi Ogata-Aoki et al. · Journal of Biological Chemistry · 2006 · 162 citations · Full text

, , +17

Structure-Based Design of Novel HIV-1 Protease Inhibitors To Combat Drug Resistance

Arun K. Ghosh, P. Sridhar, Sofiya Leshchenko et al. · Journal of Medicinal Chemistry · 2006 · 155 citations · Full text

, , +17

Potent Inhibition of HIV-1 Replication by Novel Non-peptidyl Small Molecule Inhibitors of Protease Dimerization

Yasuhiro Koh, Shintaro Matsumi, Debananda Das et al. · Journal of Biological Chemistry · 2007 · 149 citations · Full text

, , +17

1–5 of 39